Ligand validation:6Q3A

OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate

OLC is a Ligand Of Interest in 6Q3A designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6Q3A_OLC_A_604	0%	54%	0.824	0.343	0.82	0.95	2	1	1	0	100%	1
5N6L_OLC_A_619	31%	56%	0.196	0.888	0.73	0.94	1	1	0	0	88%	0.88
5N6H_OLC_A_601	27%	48%	0.203	0.937	0.93	1.06	1	1	0	0	52%	0.52
5VRH_OLC_A_608	18%	55%	0.217	0.805	0.91	0.84	1	1	5	0	100%	1
5VRG_OLC_A_601	14%	50%	0.243	0.795	1.02	0.9	1	1	3	0	100%	1
8Q2P_OLC_A_2412	14%	57%	0.248	0.796	0.68	0.97	1	1	1	0	100%	0.9
7Z0C_OLC_A_803	63%	52%	0.097	0.892	0.82	1.04	1	2	2	0	100%	1
4N6H_OLC_A_1222	63%	56%	0.117	0.932	0.81	0.87	1	1	0	0	88%	0.88
5IU4_OLC_A_2429	61%	59%	0.136	0.926	0.8	0.78	2	1	1	0	100%	1
6G7H_OLC_A_310	61%	92%	0.117	0.905	0.26	0.26	-	-	0	0	100%	1
7B0O_OLC_A_302	59%	54%	0.146	0.929	0.69	1.07	1	1	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.